» Articles » PMID: 26082777

Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and Functions

Overview
Journal Front Immunol
Date 2015 Jun 18
PMID 26082777
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells (DCs) were initially defined as mononuclear phagocytes with a dendritic morphology and an exquisite efficiency for naïve T-cell activation. DC encompass several subsets initially identified by their expression of specific cell surface molecules and later shown to excel in distinct functions and to develop under the instruction of different transcription factors or cytokines. Very few cell surface molecules are expressed in a specific manner on any immune cell type. Hence, to identify cell types, the sole use of a small number of cell surface markers in classical flow cytometry can be deceiving. Moreover, the markers currently used to define mononuclear phagocyte subsets vary depending on the tissue and animal species studied and even between laboratories. This has led to confusion in the definition of DC subset identity and in their attribution of specific functions. There is a strong need to identify a rigorous and consensus way to define mononuclear phagocyte subsets, with precise guidelines potentially applicable throughout tissues and species. We will discuss the advantages, drawbacks, and complementarities of different methodologies: cell surface phenotyping, ontogeny, functional characterization, and molecular profiling. We will advocate that gene expression profiling is a very rigorous, largely unbiased and accessible method to define the identity of mononuclear phagocyte subsets, which strengthens and refines surface phenotyping. It is uniquely powerful to yield new, experimentally testable, hypotheses on the ontogeny or functions of mononuclear phagocyte subsets, their molecular regulation, and their evolutionary conservation. We propose defining cell populations based on a combination of cell surface phenotyping, expression analysis of hallmark genes, and robust functional assays, in order to reach a consensus and integrate faster the huge but scattered knowledge accumulated by different laboratories on different cell types, organs, and species.

Citing Articles

Complex regulation of cardiac fibrosis: insights from immune cells and signaling pathways.

Rao W, Li D, Zhang Q, Liu T, Gu Z, Huang L J Transl Med. 2025; 23(1):242.

PMID: 40022104 PMC: 11869728. DOI: 10.1186/s12967-025-06260-5.


Specific targeting of cancer vaccines to antigen-presenting cells via an endogenous TLR2/6 ligand derived from cysteinyl-tRNA synthetase 1.

Kim H, Cho S, Kim S, Song E, Jung W, Shin Y Mol Ther. 2024; 32(10):3597-3617.

PMID: 39066478 PMC: 11489552. DOI: 10.1016/j.ymthe.2024.07.014.


Characterization of intestinal mononuclear phagocyte subsets in young ruminants at homeostasis and during infection.

Baillou A, Tomal F, Chaumeil T, Barc C, Levern Y, Sausset A Front Immunol. 2024; 15:1379798.

PMID: 38756777 PMC: 11096452. DOI: 10.3389/fimmu.2024.1379798.


Saponin-based adjuvants enhance antigen cross-presentation in human CD11c CD1c CD5 CD163 conventional type 2 dendritic cells.

Ho N, Huis In t Veld L, van Eck van der Sluijs J, Heuts B, Looman M, Kers-Rebel E J Immunother Cancer. 2023; 11(8).

PMID: 37612044 PMC: 10450066. DOI: 10.1136/jitc-2023-007082.


L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic Cells.

Heo Y, Ko E, Park S, Park S, Ahn B, Yum J Cancers (Basel). 2023; 15(15).

PMID: 37568794 PMC: 10417701. DOI: 10.3390/cancers15153978.


References
1.
Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S . BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000; 165(11):6037-46. DOI: 10.4049/jimmunol.165.11.6037. View

2.
Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F . BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001; 194(12):1823-34. PMC: 2193584. DOI: 10.1084/jem.194.12.1823. View

3.
Dalod M, Salazar-Mather T, Malmgaard L, Lewis C, Asselin-Paturel C, Briere F . Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med. 2002; 195(4):517-28. PMC: 2193614. DOI: 10.1084/jem.20011672. View

4.
Schakel K, Kannagi R, Kniep B, Goto Y, Mitsuoka C, Zwirner J . 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. Immunity. 2002; 17(3):289-301. DOI: 10.1016/s1074-7613(02)00393-x. View

5.
Rissoan M, Duhen T, Bridon J, Bendriss-Vermare N, Peronne C, de Saint Vis B . Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood. 2002; 100(9):3295-303. DOI: 10.1182/blood-2002-02-0638. View